HomeCompareDIFTY vs PFE

DIFTY vs PFE: Dividend Comparison 2026

DIFTY yields 2.23% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIFTY wins by $103.17M in total portfolio value
10 years
DIFTY
DIFTY
● Live price
2.23%
Share price
$5.94
Annual div
$0.13
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$103.22M
Annual income
$95,028,161.36
Full DIFTY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — DIFTY vs PFE

📍 DIFTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDIFTYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DIFTY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DIFTY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DIFTY
Annual income on $10K today (after 15% tax)
$189.46/yr
After 10yr DRIP, annual income (after tax)
$80,773,937.16/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, DIFTY beats the other by $80,751,617.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DIFTY + PFE for your $10,000?

DIFTY: 50%PFE: 50%
100% PFE50/50100% DIFTY
Portfolio after 10yr
$51.63M
Annual income
$47,527,210.04/yr
Blended yield
92.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

DIFTY
No analyst data
Altman Z
3.7
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DIFTY buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDIFTYPFE
Forward yield2.23%6.13%
Annual dividend / share$0.13$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$103.22M$49.6K
Annual income after 10y$95,028,161.36$26,258.71
Total dividends collected$102.58M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DIFTY vs PFE ($10,000, DRIP)

YearDIFTY PortfolioDIFTY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,146$445.79$9,153$693.39+$2.0KDIFTY
2$12,855$928.73$8,593$849.25+$4.3KDIFTY
3$15,757$2,002.10$8,336$1,066.78+$7.4KDIFTY
4$21,447$4,587.06$8,437$1,384.80+$13.0KDIFTY
5$34,618$11,670.15$9,013$1,875.40+$25.6KDIFTY
6$72,251$35,209.99$10,306$2,680.72+$61.9KDIFTY
7$214,667$137,358.31$12,820$4,101.38+$201.8KDIFTY
8$992,512$762,817.94$17,673$6,826.70+$974.8KDIFTY
9$7,654,289$6,592,300.77$27,543$12,591.86+$7.63MDIFTY
10$103,218,250$95,028,161.36$49,560$26,258.71+$103.17MDIFTY

DIFTY vs PFE: Complete Analysis 2026

DIFTYStock

Daito Trust Construction Co.,Ltd. designs and constructs apartments, condominiums, rental office buildings, factories, and warehouses in Japan. It operates through Construction, Real Estate, and Other segments. The company also constructs mid- to high-rise rental condominiums in metropolitan area; produces and constructs steel frames and sells exterior products; manages rental buildings and provides customer services; and offers rental building brokerage and tenant recruitment services. In addition, it offers agency guarantee and rental building real estate agency services; constructs LP gas plants and supplies LP gas to rental buildings; supplies and sells energy, such as electric power to rental buildings; and operates elderly day care centers and nurseries. Further, the company provides home care, in-home support planning, home visit nursing care, support for people with disabilities, housekeeper referrals, and nursing care personnel introduction services; operates hotels in Malaysia; and handles financing, such as construction funds. Additionally, it sells insurance to rental housing owners and tenants; offers payment services for credit card settlements and other payment methods; provides consulting services for trust businesses centered on real estate management trusts, as well as asset succession and asset management; and offers document shipping and shredding, printing, and clerical work services. The company also engages in flexible workspace business; and management of facility reservation portal sites. The company was incorporated in 1974 and is headquartered in Tokyo, Japan.

Full DIFTY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this DIFTY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DIFTY vs SCHDDIFTY vs JEPIDIFTY vs ODIFTY vs KODIFTY vs MAINDIFTY vs JNJDIFTY vs MRKDIFTY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.